Industry news that matters to you.  Learn more

Archives for June 2014

Strand Genomics Inc. Announces Major Initiative With HCG To Provide Personalized Genomics Services For Oncology

Strand Genomics Inc. (Strand), a global leader in clinical genomics, recently announced a major initiative with Health Care Global Enterprises, Ltd (HCG) to provide personalized genomics services for oncology. Strand’s clinical genomics solutions for oncology offered by the Strand-Triesta Center for Cancer Genomics (Strand-Triesta) include both cancer risk assessment from saliva DNA as well as molecular diagnosis, treatment options and clinical trials recommendations based on tumor DNA. Representatives from Strand and HCG recently discussed their model for providing genomic services to healthcare providers globally at the 2014 American Society for Clinical Oncology Annual Meeting (ASCO) in Chicago.

BrainCare, a New Computerized Testing Solution from NeuroTrax, Promotes Brain Wellness After Stroke and Traumatic Brain Injury

NeuroTrax, a pioneer and leader in the emerging brain wellness industry, recently announced the global availability of BrainCare™, a cognitive assessment and report solution to aid clinicians in advancing brain wellness of stroke survivors and traumatic brain injury (TBI) patients.

QIAGEN and Lilly Collaborate to Co-Develop Companion Diagnostics for Simultaneous Analysis of DNA and RNA Biomarkers in Common Cancers

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) recently announced a collaboration with Eli Lilly and Company (NYSE: LLY) to co-develop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types. The agreement includes the development of tests that will be based on QIAGEN’s multi-modal, multi-analyte Modaplex analysis platform, which can process multiple sample types and biomarkers in a single test.

Personal Genome Diagnostics’ Exome Analysis And Cancer Biology Expertise Is Enabling Advances In Genome-based Cancer Therapy

Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, reported that its exome analysis services played a central role in several cancer studies recently published in leading scientific journals. PGDx’s exome analysis incorporates the company’s proprietary technology and its scientists’ deep understanding of the genomics and biology of cancer.

20/20 HealthCare Partners Collaborates with Roche to Source and Advance BioTech Innovations

20/20 HealthCare Partners LLC (20/20 HCP), a global investment group focused on early stage medical technology and life science innovation, recently announcd an agreement with Roche, in which they will source and identify novel treatments and/or technologies in the biotech arena. These areas include oncology/immuno-oncology, neurology, infectious diseases, inflammation and ophthalmology.